|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 06, 2017 ) According to Publisher, the Global Aptamers market is expected to grow from $109.23 million in 2015 to reach $346.14 million by 2022 with a CAGR of 17.9%. Huge R&D investments in bio-tech companies to develop applications in the field of diagnostics is the major factor propelling the market growth. In addition, high cost efficiency of aptamers, and technological developments are the key factors driving the market growth. However, strict regulations, ethical issues related to using aptamers, and lack of trained professional are the factors inhibiting the market growth.
For more information about this report: http://www.reportsweb.com/aptamers-global-market-outlook-2016-2022
Nucleic acid aptamers segment is witnessing a significant growth driven by increasing research and development activities and growing usage in diagnostic applications for the treatment of diseases such as autoimmune diseases, cancer and HIV/AIDS. North America is anticipated to be the largest market for aptamers, whereas Asia Pacific is projected to grow at a faster pace. Favorable government initiatives and increased research and development activities in the U.S are propelling the market growth in North America region.
Some of the key players in global aptamers market include Bioapter S.L., Base Pair Biotechnologies, Inc., Optech Biotech, Ophthotech Corporation, NOXXON Pharma AG, Neoventures Biotechnology Inc., CD Genomics, Aptagen, LLC, Am Biotechnologies, LLC,
Aptus Biotech S.L., Aptamer Solutions Ltd., Aptamer Sciences Inc., Vivonics, Inc., Trilink Biotechnologies, Inc., Somalogic, Inc., and Regado Biosciences, Inc.
Aptamer Types Covered:
- Nucleic Acid Aptamers
o DNA-Based
o RNA-Based
- Peptide Aptamers
Applications Covered:
- Diagnostics
o Biomarker Detection and Discovery
o Molecular Imaging
- Therapeutics Development
- Research and Development
o Drug Discovery and Development
o Targeted Drug Delivery
- Other Applications
o Biosensor
o Food Safety
Technologies Covered:
- SELEX
- Other Technologies
End Users Covered:
- Bio-Tech Companies
- Academia
- CRO's
- Other End Users
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001565015/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
11.1 Bioapter S.L.
11.2 Base Pair Biotechnologies, Inc.
11.3 Optech Biotech
11.4 Ophthotech Corporation
11.5 NOXXON Pharma AG
11.6 Neoventures Biotechnology Inc.
11.7 CD Genomics
11.8 Aptagen, LLC
11.9 Am Biotechnologies, LLC
11.10 Aptus Biotech S.L.
11.11 Aptamer Solutions Ltd.
11.12 Aptamer Sciences Inc.
11.13 Vivonics, Inc.
11.14 Trilink Biotechnologies, Inc.
11.15 Somalogic, Inc.
11.16 Regado Biosciences, Inc.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001565015/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
